Skip to main content
. 2016 Dec 26;47(1):56–64. doi: 10.4070/kcj.2016.0045

Table 3. Trends of AF patients according to treatment patterns, morbidity and mortality.

Medications Year
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Stroke prevention
 Aspirin 1359
(32.4)
1757
(33.7)
2051
(33.6)
2411
(34.3)
2689
(33.7)
2928
(33.3)
3197
(33.3)
3498
(33.3)
3769
(33.4)
3868
(32.3)
 Other antiplatelet agents* † 148
(3.5)
194
(3.7)
280
(4.6)
445
(6.3)
608
(7.6)
805
(9.2)
833
(8.7)
953
(9.1)
1147
(10.1)
1361
(11.3)
 Warfarin 764
(18.2)
934
(17.9)
1034
(16.9)
1151
(16.4)
1256
(15.7)
1381
(15.7)
1476
(15.4)
1679
(16.0)
1863
(16.5)
2002
(16.7)
Rate control
 Beta blocker* 948
(22.6)
1241
(23.8)
1465
(24.0)
1694
(24.1)
1889
(23.7)
2112
(24.1)
2393
(24.9)
2736
(26.1)
3034
(26.8)
3248
(27.1)
 Calcium channel blocker* 322
(7.7)
383
(7.3)
452
(7.4)
536
(7.6)
598
(7.5)
654
(7.4)
673
(7.0)
780
(7.4)
830
(7.3)
914
(7.6)
 Digoxin* 980
(23.4)
1121
(21.5)
1153
(18.9)
1194
(17.0)
1170
(14.7)
1219
(13.9)
1206
(12.5)
1327
(12.6)
1351
(12.0)
1367
(11.4)
Rhythm control
 Number of patients* 287
(6.8)
333
(6.4)
402
(6.6)
453
(6.4)
499
(6.2)
570
(6.5)
602
(6.3)
745
(7.1)
819
(7.2)
916
(7.6)
 Class Ic* 116
(2.8)
146
(2.8)
190
(3.1)
224
(3.2)
263
(3.3)
301
(3.4)
324
(3.4)
418
(4.0)
483
(4.3)
566
(4.7)
 Class III* 180
(4.3)
201
(3.9)
224
(3.7)
247
(3.5)
257
(3.2)
285
(3.2)
295
(3.1)
349
(3.3)
359
(3.2)
378
(3.2)
Hospitalization for RFCA 5 (0.43) 4 (0.30) 7 (0.01) 3 (0.20) 17 (1.01) 19 (1.11) 26 (1.41) 19 (0.85) 43 (1.71) 30 (1.09)

Values are presented as number (%). *p value for trends <0.05. Includes clopidogrel, prasugrel, and ticagrelor. Estimated by the proportion of hospitalization for RFCA out of total hospitalization number. RFCA: radiofrequency catheter ablation